Dianthus Therapeutics | MGTA - EPS Earnings Per Share

Stock Price
87.33
Daily Change
-0.06 -0.07%
Monthly
9.92%
Yearly
307.13%
Q2 Forecast
85.52

Dianthus Therapeutics reported $-1.43 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Avita Medical AUD -0.38 0 Dec/2025
Celltrion KRW 1.55K 735.24 Mar/2026
Cspc Pharmaceutical CNY 0 0.08 Dec/2025
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Divis Laboratories Ltd INR 21.98 3.99 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD -0.09 0.12 Dec/2025
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organigram Holdings CAD -0.16 0.02 Dec/2025
Organon & Co USD 0.63 0.38 Dec/2025
Ovoca Bio EUR -0.06 0.01 Jun/2025
Pharma Mar EUR 3.34 3.57 Dec/2025
Qiagen NV USD 0.52 0.01 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Sartorius EUR 1.2 0.06 Mar/2026
Sino Biopharmaceutical CNY -0.06 0.22 Dec/2025
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.57 0.1 Dec/2025
Xeris Pharmaceuticals USD 0.05 0.05 Dec/2025
Zealand Pharma A/S -8.34 2.6 Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 Sep/2025